Antimicrobial Exposure and Immune-Related Cutaneous Adverse Events During Immune Checkpoint Blockade Therapy
This cross-sectional study examines the risk for an immune-related cutaneous adverse event following antibiotic use.
Authors
- Mario E. Lacouture (ORCID: https://orcid.org/0000-0002-4818-3710)
- Alina Markova (ORCID: https://orcid.org/0000-0002-2427-3199)
- Sara Chekalil (ORCID: https://orcid.org/0000-0003-2995-410X)
- Alexander Bang (ORCID: https://orcid.org/0000-0002-1700-2411)
- Lukas Kraehenbuehl (ORCID: https://orcid.org/0000-0001-5411-5661)
- Jonathan U. Peled (ORCID: https://orcid.org/0000-0002-4029-7625)
- Kwami F. Ketosugbo (ORCID: https://orcid.org/0000-0003-1637-1941)
- Jedd D. Wolchok (ORCID: https://orcid.org/0000-0001-6718-2222)
- Stephanie Gu (ORCID: https://orcid.org/0000-0002-6416-785X)
- Jessica A. Lavery (ORCID: https://orcid.org/0000-0002-2746-5647)
- Taha Merghoub
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Cornell University (US)
- Swim Across America (US)
- University Hospital of Zurich (CH)
- Parker Institute for Cancer Immunotherapy (US)
- Kantonsspital Aarau (CH)
- Weill Cornell Medicine (US)
- New York University (US)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1001/jamadermatol.2025.4904
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00